The osteoporosis drugs
market is observing the trend of increasing awareness about the disease
and its possible management and treatment methods. With the rising incidence of
osteoporosis, many organizations are focusing on creating awareness among the
masses regarding it via various campaigns and programs. For instance, the
International Osteoporosis Foundation has tasked itself with making people
aware about the disease as well as bone health. For the same purpose, Nestlé
partnered with the foundation to spread awareness about the preventive measures
for osteoporosis.
The major factor contributing to the growth of the osteoporosis
drugs market is rapid urbanization, leading to drastic changes in the
environment and people’s lifestyle. As per the World Health Organization
figures, currently over 50.0% of the world’s population resides in urban areas,
which is expected to grow to 70.0% by 2050. Urbanization at such a large scale
has left a negative impact on the environment, as a result, affecting people’s
health. Unhealthy habits, such as inadequate physical activity, smoking,
tobacco and alcohol consumption, and low calcium diet, also affect the bone
health.
Access Detailed Report - Osteoporosis Drugs Market Revenue Estimation Report
The osteoporosis drugs market is witnessing growth due to
another major factor, i.e. the rising osteoporosis prevalence in
post-menopausal women. In women, bone growth is influenced by estrogen, a key
hormone in their body. The rapid decline of estrogen in post-menopausal women
causes increased bone resorption without an increase in bone formation, which
eventually results in decreased bone strength and bone loss. The International
Osteoporosis Foundation reported that post-menopausal women are susceptible to
fragility fractures, and one in three such women may suffer from fracture once
in their lifetime.
Hence, with more people falling prey to this degenerative
disease, the market for osteoporosis drugs would continue to flourish.
